Apmonia Therapeutics
About:
Apmonia Therapeutics is a biotech company that develops therapeutic strategies for cancer.
Website: https://apmonia-therapeutics.com
Top Investors: Bpifrance, France 2030, EIC Accelerator
Description:
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.
Total Funding Amount:
14.7M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Reims, Champagne-Ardenne, France
Founded Date:
2019-01-01
Contact Email:
contact(AT)apmonia-therapeutics.com
Founders:
Abderrahim Lachgar, Stephane Dedieu
Number of Employees:
1-10
Last Funding Date:
2024-07-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai